Stem cell study uncovers molecular pathway for enamel regeneration
Tooth enamel is the hardest substance in the human body, yet once damaged, it cannot regenerate naturally. To…
MSU researchers develop tool to observe complex molecular choreography in real time
A lot of things need to go right on a molecular level for immune cells to launch an…
Amsterdam UMC researchers overturn long-standing biological pacemaker dogma
Researchers from Amsterdam UMC have overturned a key assumption in the biological pacemaker field. In a new preclinical…
Mesenchymal drift may explain how aging cells lose their identity
A new review argues that aging may not be just a collection of molecular defects, but a progressive…
DNA-guided CRISPR system targets RNA and expands Cas12 beyond gene editing
A DNA-guided CRISPR platform could make RNA detection and control more stable, scalable, and precise, opening new routes…
INDIGO Biosciences expands reporter assay capabilities with new Transrepression Assay Services
INDIGO Biosciences today announced the launch of its Transrepression Assay Services, expanding the company’s cell-based reporter assay capabilities…
Kyoto University identifies key regulator of insulin production
A hallmark of Type 2 diabetes is the progressive loss of beta cell mass: cells in the pancreas…
SpeakOn’s dictation device is a good idea marred by platform limitations
I constantly use dictation apps such as Wispr Flow, Willow, or Typeless to reply to messages and emails…
High-resolution study maps molecular differences across six human cortical regions
A new analysis of individual brain cells across several human brain regions reveals subtle but widespread differences in…
Study explains why current BET inhibitors fail in cancer treatment
For over a decade, a class of drugs called BET inhibitors has been tested in cancer trials with…
AlphaFold Database expands with millions of predicted protein complexes
A new collaboration between EMBL’s European Bioinformatics Institute (EMBL-EBI), Google DeepMind, NVIDIA, and Seoul National University has made…
FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to…